171 related articles for article (PubMed ID: 30075577)
21. Telbivudine versus lamivudine and entecavir for treatment-naïve decompensated hepatitis B virus-related cirrhosis.
Yue-Meng W; Li YH; Wu HM; Yang J; Xu Y; Yang LH; Yang JH
Clin Exp Med; 2017 May; 17(2):233-241. PubMed ID: 27094312
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B.
Gane EJ; Wang Y; Liaw YF; Hou J; Thongsawat S; Wan M; Moon YM; Jia J; Chao YC; Niu J; Leung N; Samuel D; Hsu CW; Bao W; Lopez P; Avila C
Liver Int; 2011 May; 31(5):676-84. PubMed ID: 21457439
[TBL] [Abstract][Full Text] [Related]
23. Treatment of hepatitis B e antigen positive chronic hepatitis with telbivudine or adefovir: a randomized trial.
Chan HL; Heathcote EJ; Marcellin P; Lai CL; Cho M; Moon YM; Chao YC; Myers RP; Minuk GY; Jeffers L; Sievert W; Bzowej N; Harb G; Kaiser R; Qiao XJ; Brown NA;
Ann Intern Med; 2007 Dec; 147(11):745-54. PubMed ID: 17909201
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of telbivudine in Taiwanese chronic hepatitis B patients compared with GLOBE extension study and predicting treatment outcome by HBV DNA kinetics at week 24.
Hsu CW; Chao YC; Lee CM; Chang TT; Chen YC
BMC Gastroenterol; 2012 Dec; 12():178. PubMed ID: 23234302
[TBL] [Abstract][Full Text] [Related]
25. Significance of HBV DNA levels at 12 weeks of telbivudine treatment and the 3 years treatment outcome.
Seto WK; Lai CL; Fung J; Wong DK; Yuen JC; Hung IF; Yuen MF
J Hepatol; 2011 Sep; 55(3):522-528. PubMed ID: 21147187
[TBL] [Abstract][Full Text] [Related]
26. Hepatic flare after telbivudine withdrawal and efficacy of postpartum antiviral therapy for pregnancies with chronic hepatitis B virus.
Liu J; Wang J; Jin D; Qi C; Yan T; Cao F; Jin L; Tian Z; Guo D; Yuan N; Feng W; Zhang S; Zhao Y; Chen T
J Gastroenterol Hepatol; 2017 Jan; 32(1):177-183. PubMed ID: 27161163
[TBL] [Abstract][Full Text] [Related]
27. [Telbivudine treatment on cirrhosis resulting from chronic hepatitis B].
Liang J; Han T; Xiao SX
Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):24-7. PubMed ID: 19203447
[TBL] [Abstract][Full Text] [Related]
28. Telbivudine therapy for chronic hepatitis B: A journey to identify super-responders and to optimize treatment using the roadmap model.
Kao JH; Asselah T; Dou XG; Hamed K
J Gastroenterol Hepatol; 2017 Jan; 32(1):73-81. PubMed ID: 27515408
[TBL] [Abstract][Full Text] [Related]
29. Long-Term Telbivudine Treatment Results in Resolution of Liver Inflammation and Fibrosis in Patients with Chronic Hepatitis B.
Hou JL; Xu D; Shi G; Wan M; Goodman Z; Tan D; Xie Q; Chen C; Wei L; Niu J; Wang Q; Ren H; Wang Y; Jia J; Bao W; Dong Y; Trylesinski A; Naoumov NV
Adv Ther; 2015 Aug; 32(8):727-41. PubMed ID: 26329749
[TBL] [Abstract][Full Text] [Related]
30. [Efficacy of 104-week sequential therapy with telbivudine or entecavir in HBeAg-positive chronic hepatitis B patients with suboptimal responses to 24-week therapy with pegylated interferon-α-2a].
Luo XD; Chen XP; Chen R; Chen XF; Huang J
Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):241-5. PubMed ID: 27470620
[TBL] [Abstract][Full Text] [Related]
31. Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission.
Sun W; Zhao S; Ma L; Hao A; Zhao B; Zhou L; Li F; Song M
BMC Gastroenterol; 2017 Apr; 17(1):51. PubMed ID: 28407735
[TBL] [Abstract][Full Text] [Related]
32. Use of telbivudine in kidney transplant recipients with chronic hepatitis B virus infection: A preliminary experience.
Yap DY; Chan TM
Nephrology (Carlton); 2016 May; 21(5):438-41. PubMed ID: 26484932
[TBL] [Abstract][Full Text] [Related]
33. Comparing Efficacy of Lamivudine, Adefovir Dipivoxil, Telbivudine, and Entecavir in Treating Nucleoside Analogues Naïve for HBeAg-Negative Hepatitis B with Medium Hepatitis B Virus (HBV) DNA Levels.
Shi H; Han Z; Liu J; Xue J; Zhang S; Zhu Z; Xia J; Huang M
Med Sci Monit; 2017 Nov; 23():5230-5236. PubMed ID: 29095799
[TBL] [Abstract][Full Text] [Related]
34. [The efficacy and safety of telbivudine in korean patients with chronic hepatitis B].
Moon YM; Hwang SG; Kim BS; Rim KS; Cho M; Kim DJ; Han JY; Kim YS; Choi HS; Ahn SH
Korean J Hepatol; 2007 Dec; 13(4):503-12. PubMed ID: 18159148
[TBL] [Abstract][Full Text] [Related]
35. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.
Han GR; Cao MK; Zhao W; Jiang HX; Wang CM; Bai SF; Yue X; Wang GJ; Tang X; Fang ZX
J Hepatol; 2011 Dec; 55(6):1215-21. PubMed ID: 21703206
[TBL] [Abstract][Full Text] [Related]
36. Meta-analysis of the efficacy and safety of nucleotide/nucleoside analog monotherapy for hepatitis B virus-associated glomerulonephritis.
Wang WN; Wu MY; Ma FZ; Sun T; Xu ZG
Clin Nephrol; 2016 Jan; 85(1):21-9. PubMed ID: 26636326
[TBL] [Abstract][Full Text] [Related]
37. Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus.
Yu MM; Jiang Q; Ji Y; Wu KH; Ju LL; Tang X; Yang YF
J Clin Virol; 2014 Sep; 61(1):55-60. PubMed ID: 24994007
[TBL] [Abstract][Full Text] [Related]
38. Long-term outcome of telbivudine versus entecavir in treating higher viral load chronic hepatitis B patients without cirrhosis.
Pan HY; Pan HY; Song WY; Zheng W; Tong YX; Yang DH; Dai YN; Chen MJ; Wang MS; Huang YC; Zhang JJ; Huang HJ
J Viral Hepat; 2017 Nov; 24 Suppl 1():29-35. PubMed ID: 29082652
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B.
Wang Y; Thongsawat S; Gane EJ; Liaw YF; Jia J; Hou J; Chan HL; Papatheodoridis G; Wan M; Niu J; Bao W; Trylesinski A; Naoumov NV
J Viral Hepat; 2013 Apr; 20(4):e37-46. PubMed ID: 23490388
[TBL] [Abstract][Full Text] [Related]
40. [Short-term results of telbivudine versus entecavir treatments in HBeAg-positive chronic hepatitis B patients in China].
Shi KQ; Zhang DZ; Guo SH; He H; Wang ZY; Shi XF; Zeng WQ; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2008 Sep; 16(9):641-5. PubMed ID: 18822200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
